FindMyKOL

Seymour Huberfeld, MD

Basic profile

Northwell Health

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionNew Hyde Park, NY · NortheastSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLFindMyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Seymour Huberfeld is a Respiratory physician affiliated with Northwell Health. OpenAlex indexes 13 publications with 281 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
13publications

Publications indexed by OpenAlex. Counts exclude supporting files.

281citations

Citations across these publications.

7h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Inspire Medical Systems, Inc.
    Program year20241 payment
    $108
  • Amgen Inc.
    Program year20241 payment
    $19
  • Boston Scientific Corporation
    Program year20221 payment
    $162

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    67.5%
    Interleukin-5 Receptor alpha-directed Cytolytic Antibody30.3%
    Benralizumab99%Fasenra1%
    Part D + Part B<11 patients
    Corticosteroid22.5%
    Trelegy Ellipta38%Fluticasone Propionate12%Breztri Aerosphere12%Flovent Hfa12%Breo Ellipta10%Symbicort7%Qvar Redihaler2%Dulera2%Arnuity Ellipta2%Pulmicort Flexhaler1%Asmanex Hfa1%Budesonide1%
    Part D<11 patients

    + 7 more classes in this area

  • Metabolism & gastrointestinal

    9.9%
    Proton pump inhibitor3.4%
    Omeprazole54%Pantoprazole Sodium29%Esomeprazole Magnesium9%Dexlansoprazole Dr8%
    Part D<11 patients
    Corticosteroid2.9%
    Prednisone100%
    Part D≥106 patients

    + 8 more classes in this area

  • Cardiovascular

    8.4%
    Statin3.2%
    Atorvastatin Calcium44%Simvastatin41%Rosuvastatin Calcium15%
    Part D<11 patients
    Beta blocker1.6%
    Metoprolol Succinate61%Atenolol28%Carvedilol11%
    Part D<11 patients

    + 6 more classes in this area

Where care is delivered (Part B)0.2% facility · 99.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”